Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases by Nicholas Black, Joshua Bradley, Fardad Soltani, John P. Farrant, Josephine H. Naish, Matthias Schmitt, Maya H. Buch, Christopher A. Miller

Get full text

Development and Validation of Imaging‐Free Myocardial Fibrosis Prediction Models, Association with Outcomes, and Sample Size Estimation for Phase 3 Trials by Nicholas Black, Joshua Bradley, Gavin Lewis, Jakub Lagan, Christopher Orsborne, Fardad Soltani, John P. Farrant, Theresa McDonagh, Matthias Schmitt, João L. Cavalcante, Martin Ugander, Javed Butler, Mark C. Petrie, Christopher A. Miller, Erik B. Schelbert

Get full text

Considerations for drug trials in hypertrophic cardiomyopathy by John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller

Get full text